These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 23726662

  • 1. Population pharmacokinetic analysis of blood concentrations of robenacoxib in dogs with osteoarthritis.
    Fink M, Letellier I, Peyrou M, Mochel JP, Jung M, King JN, Gruet P, Giraudel JM.
    Res Vet Sci; 2013 Oct; 95(2):580-7. PubMed ID: 23726662
    [Abstract] [Full Text] [Related]

  • 2. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.
    Reymond N, Speranza C, Gruet P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2012 Apr; 35(2):175-83. PubMed ID: 21480932
    [Abstract] [Full Text] [Related]

  • 3. Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.
    Toutain CE, Heit MC, King SB, Helbig R.
    BMC Vet Res; 2017 Nov 28; 13(1):359. PubMed ID: 29179750
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetic analysis of blood and joint synovial fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.
    Silber HE, Burgener C, Letellier IM, Peyrou M, Jung M, King JN, Gruet P, Giraudel JM.
    Pharm Res; 2010 Dec 28; 27(12):2633-45. PubMed ID: 20922466
    [Abstract] [Full Text] [Related]

  • 5. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
    King JN, Jung M, Maurer MP, Schmid VB, Seewald W, Lees P.
    Am J Vet Res; 2013 Mar 28; 74(3):465-72. PubMed ID: 23438125
    [Abstract] [Full Text] [Related]

  • 6. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.
    Schmid VB, Spreng DE, Seewald W, Jung M, Lees P, King JN.
    J Vet Pharmacol Ther; 2010 Apr 28; 33(2):118-31. PubMed ID: 20444036
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.
    Pelligand L, King JN, Toutain PL, Elliott J, Lees P.
    J Vet Pharmacol Ther; 2012 Feb 28; 35(1):19-32. PubMed ID: 21767277
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs.
    Borer LR, Seewald W, Peel JE, King JN.
    J Vet Pharmacol Ther; 2017 Apr 28; 40(2):148-157. PubMed ID: 27493016
    [Abstract] [Full Text] [Related]

  • 9. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
    Pelligand L, King JN, Hormazabal V, Toutain PL, Elliott J, Lees P.
    J Vet Pharmacol Ther; 2014 Aug 28; 37(4):354-66. PubMed ID: 24628410
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.
    King JN, Dawson J, Esser RE, Fujimoto R, Kimble EF, Maniara W, Marshall PJ, O'Byrne L, Quadros E, Toutain PL, Lees P.
    J Vet Pharmacol Ther; 2009 Feb 28; 32(1):1-17. PubMed ID: 19161451
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats.
    Heit MC, Stallons LJ, Seewald W, Thompson CM, Toutain CE, King SB, Helbig R.
    BMC Vet Res; 2020 Sep 25; 16(1):355. PubMed ID: 32988403
    [Abstract] [Full Text] [Related]

  • 15. Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations.
    Toutain CE, Brossard P, King SB, Helbig R.
    BMC Vet Res; 2018 Aug 17; 14(1):242. PubMed ID: 30119677
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis.
    Bennett D, Eckersall PD, Waterston M, Marchetti V, Rota A, McCulloch E, Sbrana S.
    BMC Vet Res; 2013 Mar 01; 9():42. PubMed ID: 23452411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can liquorice extract and herbal solution prevent colonic mucosa damage caused by robenacoxib in dogs?
    Szweda M, Szarek J, Lew M, Szarek-Bęska A, Gulda D.
    Pol J Vet Sci; 2015 Mar 01; 18(4):793-8. PubMed ID: 26812822
    [Abstract] [Full Text] [Related]

  • 20. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M, Lees P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2009 Feb 01; 32(1):41-8. PubMed ID: 19161454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.